Eben Tessari - Jul 15, 2021 Form 4 Insider Report for Kiniksa Pharmaceuticals, Ltd. (KNSA)

Role
Chief Operating Officer
Signature
Madelyn Zeylikman, Attorney-in-Fact for Eben Tessari
Stock symbol
KNSA
Transactions as of
Jul 15, 2021
Transactions value $
$12,416
Form type
4
Date filed
3/18/2022, 04:36 PM
Previous filing
Jun 21, 2021
Next filing
Sep 7, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KNSA Class A Common Share Award $9.97K +868 +0.82% $11.49 107K Jul 15, 2021 Direct F1
transaction KNSA Class A Common Share Award $9.34K +970 +0.91% $9.63 108K Jan 15, 2022 Direct F2
transaction KNSA Class A Common Share Options Exercise +1.96K +1.82% 110K Mar 16, 2022 Direct F3
transaction KNSA Class A Common Share Tax liability -$6.9K -681 -0.62% $10.13 109K Mar 16, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KNSA Restricted Share Unit Options Exercise $0 -1.96K -25% $0.00 5.89K Mar 16, 2022 Class A Common Share 1.96K Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person is voluntarily reporting the acquisition of these shares pursuant to the Issuer's 2018 Employee Share Purchase Plan for the purchase period of January 1, 2021 to July 15, 2021. The acquisition of such shares was exempt pursuant to Rule 16b-3(c).
F2 The reporting person is voluntarily reporting the acquisition of these shares pursuant to the Issuer's 2018 Employee Share Purchase Plan for the purchase period of July 16, 2021 to January 15, 2022. The acquisition of such shares was exempt pursuant to Rule 16b-3(c).
F3 Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.
F4 The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, March 16, 2021.